Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Target Trial Emulation for Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

NCT06876727 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06876727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06876727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Target Trial Emulation for Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2003
Completion date
September 30, 2023
Enrollment
8,325 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysms (aaa), endovascular aneurysm repair (evar)